21256 ⎘
Medicinal preparations containing active ingredients not provided for in groups - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
CATHEPSIN INHIBITORS FOR PREVENTING OR TREATING VIRAL INFECTIONS
#6002Methods for Enhancing Cytotoxic Cancer Therapy Through Inhibition of ATG4B
#6003COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#6004CDK INHIBITORS
#6005Methods
#6006Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors
#6007METHODS FOR OPTIMIZING CFTR-MODULATOR THERAPY
#6008Methods and compositions for treatment of epileptic disorders
#6009METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#6010METHODS AND COMPOSITIONS FOR TREATING OBESITY, PREVENTING WEIGHT GAIN, PROMOTING WEIGHT LOSS, PROMOTING SLIMMING, OR TREATING OR PREVENTING THE DEVELOPMENT OF DIABETES
#6011METHODS OF TREATMENT FOR FUNCTIONAL DECLINE IN HIPPOCAMPUS, FOR IMPROVING RECOGNITION MEMORY ACCURACY, AND FOR IMPROVING HIPPOCAMPAL NEURONAL FUNCTION
#6012ANTI-CANCER ACTIVITY OF ADAMANTANE DERIVATIVES
#6013NANOPARTICLE COMPRISING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT
#6014Protection of Polyunsaturated Fatty Acids, Lipid-Soluble Vitamins, and Lipid-Soluble Medicaments from Oxidation
#6015FORMULATIONS OF GLUCAGON-LIKE-PEPTIDE-2 (GLP-2) ANALOGUES
#6016METHODS OF TREATING CANCER
#6017MATERIALS AND METHODS FOR EVALUATING AND TREATING NEUROMYELITIS OPTICA (NMO)
#6018COMBINATION THERAPY FOR CANCERS WITH BRAF MUTATION
#6019COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES
#6020THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE
#6021HETEROCYCLIC SPIRO COMPOUNDS AND METHODS OF USE
#6022HETEROARYL COMPOUNDS AS EGFR INHIBITORS AND THEIR USES
#6023SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINE COMPOUNDS AS KINASE INHIBITORS AND USE THEREOF
#6024Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs
#6025COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF THE ANDROGEN RECEPTOR
#6026SUBSTITUTED PYRIMIDINE DERIVATIVES AS NICOTINIC ACETYLCHOLINESTERASE RECEPTOR ALPHA 6 MODULATOR
#6027SUBSTITUTED INDOLE COMPOUNDS
#6028Linkers for antibody drug conjugates
#6029METHODS AND COMPOSITIONS FOR TREATMENT OF FRIEDREICH'S ATAXIA
#6030USE OF PSILOCYBIN IN CANCER TREATMENT
#6031COMPOSITIONS COMPRISING WATER THAT EXHIBITS INCREASED CELL PERMEABILITY AND METHODS OF USE THEREOF
#6032BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same
#6033CHIMERIC TIM4 RECEPTORS AND USES THEREOF
#6034Combinations of Modalities for the Treatment of Diabetes
#6035IMMUNOGENIC PEPTIDE
#6036PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT COMPRISING FUSION PROTEIN INCLUDING IL-2 PROTEIN AND CD80 PROTEIN AND ANTICANCER DRUG
#6037Cancer immunotherapy using virus particles
#6038Use of TLR agonist and anti-CD47 agent to enhance phagocytosis of cancer cells
#6039ORAL HYALURONIC ACID COMPOSITION
#6040COMPOSITIONS COMPRISING DECITABINE AND TETRAHYDROURIDINE AND USES THEREOF
#6041METHODS OF TREATING MASTITIS WITH AN ORTHOSOMYCIN ANTIMICROBIAL COMPOUND
#6042METHODS FOR TREATING GI TRACT DISORDERS
#6043Treatment of Conditions Associated With Decreased Folate in Cerebral Spinal Fluid
#6044Treatment of hair loss disorders with deuterated JAK inhibitors
#6045TREATMENT OF URTICARIA USING JAK INHIBITORS
#6046SHP2 Inhibitor Compositions and Methods for Treating Cancer
#6047COMPOSITIONS AND METHODS FOR TREATING CANCER
#6048Pyridine and Pyrazine derivative for the Treatment of CF, COPD, and Bronchiectasis
#6049CHLORINATED TETRALIN COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS
#6050SULCARDINE ADMINISTRATION FOR TREATMENT OF ACUTE ATRIAL FIBRILLATION 94919.0739.717301US
#6051METHOD OF INDUCTION OF TUMOR ASSOCIATED ANTIGENS WITH BRYOSTATIN
#6052Psychoactive medicines and their use for treating psychiatric and neurological conditions and disorders
#6053Nutritional Formulas Comprising Medium Chain Fatty Acids or Esters Thereof and Methods Related Thereto
#6054Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib
#6055ANTITHROMBIN HEPARAN SULFATE FOR DETECTION AND TREATMENT OF CANCER
#6056APTAMER-siRNA FUSIONS
#6057COMPOSITIONS AND METHODS TO TREAT CANCER
#6058TARGETED CONJUGATES COMPRISING MODIFIED SIRNA
#6059METHODS AND COMPOSITIONS FOR POTENTIATING ANTITUMORAL IMMUNE RESPONSES THROUGH TARGETING OF NTPDASE3
#6060REVERSAL BINDING AGENTS FOR ANTI-NATRIURETIC PEPTIDE RECEPTOR I (NPRI) ANTIBODIES AND USES THEREOF
#6061ENHANCEMENT OF ANTI-TUMOR PHAGOCYTOSIS
#6062PRECISION MEDICINE FOR CHOLESTEROL TREATMENT
#6063NOVEL RECOMBINANT FRAGMENTS OF FIBRILLIN-1 AND METHODS OF USE THEREOF
#6064Treprostinil prodrugs
#60653-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
#6066ROR-GAMMA INHIBITORS FOR THE TREATMENT OF ROR-GAMMA-DEPENDENT CANCER
#6067Small molecule inhibitors targeting sporulation
#6068Novel CYP3A4-Specific Inhibitors and Methods of Using Same
#6069TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY
#6070CAPSID INHIBITORS FOR THE PREVENTION OF HIV
#6071SULFONAMIDES WITH EGFR INHIBITION ACTIVITIES AND THEIR USE THEREOF
#6072ISOINDOLINONE AMIDE COMPOUNDS USEFUL TO TREAT DISEASES ASSOCIATED WITH GSPT1
#6073SOLID FORMS OF AN N-TERMINAL DOMAIN ANDROGEN RECEPTOR INHIBITOR AND USES THEREOF
#6074COMPOSITIONS AND METHODS FOR MAKING AND USING DOUBLE NETWORK HYDROGELS
#6075COMPOSITIONS TARGETING TUMOR ASSOCIATED MACROPHAGES AND METHODS USING SAME
#6076Bi-functional molecules to degrade circulating proteins
#6077CDK INHIBITORS AND PHARMACEUTICAL USES THEREOF
#6078Formulated and/or co-formulated liposome compositions containg TGFb antagonist prodrugs useful in the treatment of cancer and methods thereof
#6079LYMPH DIRECTING PRODRUGS
#6080Topical therapeutic formulations
#6081Methods of Using Compositions Comprising Variants and Fusions of FGF19 Polypeptides for Treatment of Metabolic Disorders and Diseases
#6082MODULATING LYMPHATIC VESSELS IN NEUROLOGICAL DISEASE
#6083COMPOSITIONS AND METHODS FOR PREVENTING, ATTENUATING, AND TREATING MEDICAL CONDITIONS WITH sHDL NANOPARTICLES
#6084METHODS AND COMPOSITIONS FOR TREATING CD44+ CANCERS
#6085USE OF COMPOUND, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF IMMUNE OR METABOLIC DISORDERS, PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ILLNESSES CAUSED BY OR ASSOCIATED WITH VIRUSES
#6086REDUCTION OF VIRAL INFECTIONS
#6087Neem for treatment of RLS
#6088AMANITA MUSCARIA COMPOUNDS
#6089COMPOSITIONS AND METHODS
#6090AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF DIAPER RASH, ATHLETE’S FOOT, CONTACT DERMATITIS, PERSPIRATION, AND BODY ODOR
#6091ANTI-CLAUDIN18.2 ANTIGEN-BINDING FRAGMENT OR ANTIBODY, AND USE THEREOF18255119
#6092METHODS FOR ACTIVATING IMMUNE CELLS AND TREATING OCULAR NEOVASCULARIZATION
#6093Therapeutic composition and methods
#6094THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B
#6095Nicotinyl riboside compounds and their uses
#6096Compositions And Methods For Inducing Apopotosis In Anaerobic Cells And Related Clinical Methods For Treating Cancer And Pathogenic Infections
#6097Compositions and Methods For Treating Neurological Conditions
#6098USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH EPILEPSY SYNDROMES IN PATIENTS TAKING BRIVARACETAM
#6099ABIRATERONE PRODRUGS
#6100Betulin-containing birch bark extracts and their formulation
#61016-ARYL-4-MORPHOLIN-1-YLPYRIDONE COMPOUNDS USEFUL FOR THE TREATMENT OF CANCER AND DIABETES
#6102HETEROCYCLIC COMPOUNDS AND USES THEREOF
#6103COMPOUNDS AND METHODS OF TREATING CANCERS
#6104TREATING VIRAL INFECTION WITH NMD INHIBITORS
#6105PHARMACEUTICAL FORMULATIONS OF A PHENOLIC TRPV1 AGONIST PRODRUG
#6106METABOLISM ENHANCING COMPOSITIONS
#6107Metabolism enhancing compositions
#6108Methods and Compositions for Treating Psychotic Disorders
#6109PHARMACEUTICAL COMPOSITION
#6110PHARMACEUTICAL COMPOSITION
#6111THERAPY OF POST-OPERATIVE EMESIS WITH AMISULPRIDE
#6112DEUTERATED OXOPHENYLARSINE COMPOUND AND USE THEREOF
#6113USE OF LEVODOPA, CARBIDOPA AND ENTACAPONE FOR TREATING PARKINSON'S DISEASE
#6114COMPOSITIONS AND USES THEREOF FOR TREATING OR PREVENTING VIRAL INFECTIONS
#6115SYSTEM AND METHOD FOR WOUND TREATMENT AND IRRIGATION
#6116Dosing Regimens for Treatment of Proliferative Disorders
#6117Targeted Nanomedicine for Treating Vascular Disorders
#6118NANT CANCER VACCINE STRATEGIES
#6119NUCLEIC ACID BIOMARKER AND USE THEREOF
#6120PROGNOSTIC BIOMARKERS FOR BREAST CANCER
#6121ENGINEERED VIRAL VECTOR REDUCES INDUCTION OF INFLAMMATORY AND IMMUNE RESPONSES
#6122COMPOSITIONS TARGETING WDR37 AND METHODS OF USE THEREOF
#6123Intestinal organoid co-culture systems and methods for treating or preventing a disease or disorder associated with immune response-mediated tissue injury
#6124AMINO ACID POLYMER-PLATINUM ANTICANCER DRUG CONJUGATES
#6125ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS
#6126COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS
#6127METHODS FOR TREATMENT OF PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA WITH MOSUNETUZUMAB AND LENALIDOMIDE
#6128Anti-CD40L antibodies and methods for treating CD40L-related diseases or disorders
#6129METHODS AND COMPOSITIONS FOR TREATMENT OF THYROID EYE DISEASE
#6130METHODS OF INDUCING AN IMMUNOMODULATORY TUMOR RESPONSE
#6131METHOD FOR PREDICTING AND EVALUATING THERAPEUTIC EFFECT IN DISEASES RELATED TO IL-6 AND NEUTROPHILS
#6132TARGETING OF PERI-NECROTIC TUMOR CELLS
#6133COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNODEFICIENCY
#6134DELTA T-CELL OR GAMMA RECEPTOR CHAINS OR PARTS THEREOF FOR TREATING OVARIAN CANCER
#6135PROTEINS FOR THE TREATMENT OF EPITHELIAL BARRIER FUNCTION DISORDERS
#6136NEW COMPOUND
#6137Thienopyranones and Furanopyranones as Kinase, Bromodomain, and Checkpoint Inhibitors
#6138CD73 COMPOUNDS
#6139Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof
#6140METHODS FOR TREATING CANCER AND NON-NEOPLASTIC CONDITIONS
#6141POTENT AND SELECTIVE IRREVERSIBLE INHIBITORS OF IRAK1
#6142cGAS antagonist compounds
#6143COMPOSITIONS AND METHODS FOR TREATING CANCER
#6144Crystalline bufotenidine compounds
#6145SUBSTITUTED AROMATIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF
#6146SYSTEMS AND METHODS FOR CLEANING SURFACES OF A WORKPIECE
#6147METHODS AND COMPOSITIONS COMPRISING TUMOR SUPPRESSOR GENE THERAPY FOR THE INHIBITION OF PATHOGENS
#6148NANOPARTICLES CONTAINING MULTIPLE CLEAVABLE PRODUGS FOR CANCER THERAPY
#6149CISPLATIN ANALOGUE WITH POTENT ANTI-CANCER EFFECTS AND SYNTHESIS THEREOF
#6150Compositions and methods for treatment of neurological disorders
#6151METHODS FOR PREVENTING ORAL SENSITIZATION
#6152Coronavirus vaccine
#6153VACCINE ADJUVANTS AND FORMULATIONS
#6154CD80 EXTRACELLULAR DOMAIN POLYPEPTIDES AND THEIR USE IN CANCER TREATMENT
#6155ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS
#6156IMMUNE CHECKPOINT SUPPRESSANT
#6157AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION
#6158METHOD FOR CONSTRUCTING STRICTLY ANAEROBIC SALMONELLA, CONSTRUCTED STRICTLY ANAEROBIC SALMONELLA AND APPLICATION THEREOF
#6159PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS
#6160CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL EXPRESSING CXCL12 RECEPTOR
#6161TREATMENT FOR METHAMPHETAMINE CARDIOVASCULAR DISEASE
#6162PRE-EXPOSURE PROPHYLAXIS OF HIV INFECTIONS
#6163Therapeutically active compounds and their methods of use
#6164ANTI-HAIR-LOSS COMPOSITION
#6165Pharmaceutical Combinations for Treating Cancer
#6166METHODS AND COMPOSITIONS FOR SLEEP DISORDERS AND OTHER DISORDERS
#6167COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF VIRAL INFECTIONS
#6168DOSAGE REGIMEN FOR A NR2B-NMDA RECEPTOR NAM FOR THE TREATMENT OF DEPRESSION
#6169METHOD FOR TREATMENT OF DISEASE CAUSED OR AGGRAVATED BY MICROORGANISMS OR RELIEVING SYMPTOMS THEREOF
#6170METHOD OF TREATING AND PREVENTING VIRAL INFECTION
#6171METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS
#6172COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST
#6173USE OF DEXPRAMIPEXOLE FOR THE TREATMENT OF MODERATE TO SEVERE ASTHMA
#6174USE OF DEXPRAMIPEXOLE FOR THE TREATMENT OF MODERATE TO SEVERE ASTHMA
#6175METHODS OF INHIBITING TUMOR METASTASIS
#6176Pharmaceutical composition for preventing or treating inflammatory bowel disease acting as a functional antagonist for S1PR1 and S1PR4
#6177METHODS AND COMPOSITIONS FOR TREATING EYE DISEASES
#6178SAROGLITAZAR AND MYRISTIC ACID FOR USE IN THE TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS)
#6179BENEFITS OF SUPPLEMENTATION WITH N-ACETYLCYSTEINE AND GLYCINE TO IMPROVE GLUTATHIONE LEVELS
#6180OVARIAN CANCER VACCINES
#6181TOPICAL COMPOSITIONS AND USES THEREOF
#6182AMINO ALCOHOL IONIZABLE LIPIDS
#6183PHARMACEUTICAL CAPSULE CONTAINING AT LEAST TWO TABLETS
#6184MULTIFUNCTIONAL pO2/pH-SENSITIVE THERANOSTIC LIPOSOME NANOCARRIERS AND METHODS OF USING SAME
#6185BIOADHESIVE FILM AND METHODS OF USE THEREOF
#6186DRONE BASED SECURITY SYSTEM
#6187METHODS, KITS, AND SYSTEMS FOR PREDICTING PATIENT OUTCOMES
#6188COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING, AND/OR PREVENTING VIRAL INFECTIONS
#6189ANTI-A2AP ANTIBODIES AND USES THEREOF
#6190Antibodies that target HIV GP120 and methods of use
#6191ANTI-ANGIOGENIC AGENT AND METHODS OF USING SUCH AGENT
#6192DOSING REGIMENS FOR CYCLIN-DEPENDENT KINASE 7 (CDK7) INHIBITORS
#6193THERAPEUTIC COMPOUNDS USEFUL FOR THE PROPHYLACTIC OR THERAPEUTIC TREATMENT OF AN HIV VIRUS INFECTION
#6194TARGETED, INTRACELLULAR DELIVERY OF THERAPEUTIC PEPTIDES USING SUPRAMOLECULAR NANOMATERIALS
#6195POLY(2-OXAZOLINE)N-f-MLF DERIVATIVE CONJUGATES THAT INHIBIT FORMYL PEPTIDE RECEPTORS FOR THE TREATMENT OF DISEASE
#6196ALC1 Inhibitors and Synergy with PARPi
#6197Cisplatin analogue with potent anti-cancer effects and synthesis thereof
#6198COMBINATION THERAPIES WITH CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING CELLS
#6199CD70 COMBINATION THERAPY
#6200COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS
#6201ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF
#6202TREATMENT OF DANON DISEASE
#6203METHODS FOR TREATING ACUTE CONDITIONS USING LIPID BINDING PROTEIN-BASED COMPLEXES
#6204PROCESSES FOR MAKING AND USING A MESENCHYMAL STEM CELL DERIVED SECRETOME
#6205SCAFFOLDS TO TREAT SOLID TUMOR CELLS AND ESCAPE VARIANTS
#6206COMPOSITIONS AND METHODS FOR CD7 MODIFICATION
#6207METHODS FOR TREATING AUTOIMMUNE DISEASES
#6208USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH HERPES SIMPLEX VIRUS
#6209CARDIO- AND RENOPROTECTIVE ANTIDIABETIC THERAPY
#6210PPARAXANTHINE-BASED COMPOSITIONS FOR INHIBITING INFLAMMATION, IMPROVING JOINT HEALTH, AND ENHANCING IMMUNE FUNCTION
#6211Cancer treatments using combinations of CDK and ERK inhibitors
#6212CDK INHIBITORS
#6213COMPOSITIONS AND METHODS FOR THE TREATMENT OF ADDICTION AND OTHER NEUROPSYCHIATRIC DISORDERS
#6214Combination Therapy for Treating or Preventing Depression or Other Mood Diseases
#6215Methods of treating pruritus
#6216COMBINATION OF COMPOUNDS FOR USE IN THERAPY
#6217METHODS OF TREATING HERPES VIRAL INFECTION WITH 4-PHENYLBUTYRATE (PBA) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#6218USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY
#6219BACTERIAL GENE-ASSOCIATED METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING COLORECTAL CANCER
#6220PH20 polypeptide variants, formulations and uses thereof
#6221PH20 polypeptide variants with a modification at position 309 of the PH20 polypeptide and a method of making thereof
#6222NANOPARTICLE-MEDIATED IMMUNE CELL MANUFACTURE AND USE THEREOF
#6223ANTI-OPG ANTIBODIES
#6224ILT-BINDING AGENTS AND METHODS OF USE THEREOF
#6225METHOD FOR TREATING PNEUMONIA, INCLUDING COVID-19 PNEUMONIA, WITH AN IL6 ANTAGONIST
#6226Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors
#6227Methods for treating diabetes, hepatitis, and/or inflammatory liver disease
#6228METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH SARS-COV-2
#6229LUNG TREATMENT COMPOSITIONS
#6230NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF
#6231CARDIOPROTECTIVE LIPIDS AND METHODS OF USE
#6232KRAS G12C INHIBITORS
#6233HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES
#6234HEPATITIS B CORE PROTEIN MODULATORS
#6235METHODS AND COMPOSITIONS FOR PRODUCING TARGETED MICROBUBBLES
#6236ANTI-MSLN BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
#6237GPC3 BINDING AGENTS, CONJUGATES THEREOF AND METHODS OF USING THE SAME
#6238A PEPTIDE SAPORIN CONJUGATE FOR THE TREATMENT OF CANCER
#6239SELF-REPAIRING BIOMIMETIC LUBRICANTS AND METHODS OF MAKING AND USING SAME
#6240PHARMACEUTICAL COMPOSITION FOR TOPICAL USE COMPRISING A POLYMER IN THE FORM OF A PULVERULENT SOLID AS THICKENING AGENT
#6241NK CELLS OR T CELLS EXPRESSING CHIMERIC HEMATOPOIETIC GROWTH FACTOR RECEPTORS AND METHODS OF USE
#6242METHODS TO TREAT CANCER AND VACCINATE FROM CANCEROUS CELL RECURRENCE
#6243MITAPIVAT THERAPY AND MODULATORS OF CYTOCHROME P450
#6244Porcine Collagen Compositions and Methods of Use Thereof
#6245METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#6246Compositions and Methods for Managing Weight
#6247PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SQUIRREL FIBROMA VIRUS AND REOVIRUS
#6248USE OF A BIRNAVIRUS ALONE OR IN COMBIMATION THERAPY FOR THE TREATMENT OF A DISEASE CAUSED BY A NIDOVIRUS
#6249MICROBIOME MEDIATED INDUCTION OF IMMUNE TOLERANCE AND RESOLUTION OF INFLAMMATION
#6250ENGINEERED PROBIOTIC COMPOSITIONS AND USES THEREOF
#6251BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T CELLS
#6252TREATMENT OF LIMB ISCHEMIA BY BONE MARROW STEM CELLS AND MODIFICATION OF DISEASED MICROENVIRONMENT
#6253METHODS AND COMPOSITIONS FOR EXTENDING LIFESPAN
#6254CD73 INHIBITORS AND PHARMACEUTICAL USES THEREOF
#6255Compositions and Methods For Treating Migraine
#6256CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USE
#6257NOVEL METHODS
#6258APILIMOD COMPOSITIONS AND METHODS OF USE
#6259RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS
#6260Methods of Managing Cocaine or Other Drug Addictions
#6261METHODS OF TREATING CANCER WITH A COMBINATION OF TUCATINIB AND AN ANTI-PD-1/ANTI-PD-L1 ANTIBODY
#6262BIARYL ETHER UREA COMPOUNDS
#6263CARBOSTYRIL DERIVATIVES AND MOOD STABILIZERS FOR TREATING MOOD DISORDERS
#6264Methods and compositions for treating retina-associated disease using CCR3-inhibitors
#6265METHODS OF MANAGING CONDITIONED FEAR WITH NEUROKININ RECEPTOR ANTAGONISTS
#6266Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
#6267USE OF DRUGS THAT STIFFEN MATURE GAMETOCYTES FOR BLOCKING TRANSMISSION OF PLASMODIUM PARASITES
#6268Uses of Dihydroorotate Dehydrogenase Inhibitors
#6269C-PHYCOCYANIN FOR USE IN THE TREATMENT AND/OR PREVENTION OF PERIPHERAL NEUROPATHY
#6270METHODS OF TREATING HYPERTRIGLYCERIDEMIA
#6271O-ACETYLSERINE FOR THE USE THEREOF IN THE PREVENTION AND TREATMENT OF GLUCOSE INTOLERANCE AND THE ASSOCIATED DISEASES
#6272Methods and Compositions for Preventing and Treating Auditory Dysfunctions
#6273PHARMACEUTICAL COMPOSITION COMPRISING EICOSAPENTAENOIC ACID AND NICOTINIC ACID AND METHODS OF USING SAME
#6274Methods for Dopamine Modulation in Human Neurologic Diseases
#6275SPHINGOSINE PATHWAY MODULATING COMPOUNDS FOR THE TREATMENT OF CANCERS
#6276STABLE PROLONGED RELEASE FORMULATION OF VITAMIN C AND A PROCESS FOR PREPARATION THEREOF
#6277Hollow silica spheres with nested iron oxide particles
#6278Powder blend processability improvements through minimal amounts of synergistically selected surface coating agents
#6279COMPOSITIONS, METHODS & SYSTEMS FOR RESPIRATORY DELIVERY OF TWO OR MORE ACTIVE AGENTS
#6280Methods of Assigning a COVID Pathological Type and Compositions for Practicing the Same, and Methods of Treating a Subject for Chronic COVID-19
#6281Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism
#6282CIRCULATING miRNA AND PROTEIN BIOMARKERS FOR FACIOSCAPULOHUMERAL DYSTROPHY
#6283Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
#6284MODIFIED ONCOLYTIC VIRUS
#6285PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS COMPRISING IL-31 ANTAGONIST AS ACTIVE INGREDIENT
#6286COMPOSITIONS AND METHODS FOR TREATMENT OF DISEASES INVOLVING CXCL1 FUNCTION
#6287Fully Human Monoclonal Antibodies that Broadly Neutralize SARS-COV-2
#6288CYCLIC PEPTIDE TYROSINE TYROSINE COMPOUNDS AS MODULATORS OF NEUROPEPTIDE Y RECEPTORS
#6289LYSIN-ANTIMICROBIAL PEPTIDE (AMP) POLYPEPTIDE CONSTRUCTS, LYSINS, ISOLATED POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF
#6290MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS
#6291Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
#6292MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR
#6293CDK Inhibitors And Their Use As Pharmaceuticals
#6294MODULATORS OF THE INTEGRATED STRESS PATHWAY
#6295PRODRUG COMPOUNDS OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND METHODS OF SYNTHESIZING THE SAME
#6296COMBINATION THERAPY
#6297Liquid Composition Comprising Cereal Beta-Glucan or a Cereal Extract Comprising Beta-Glucan
#6298NEW ADJUVANT TO IMPROVE THE INNATE IMMUNITY
#6299AMIDATED PEPTIDES AND THEIR DEAMIDATED COUNTERPARTS DISPLAYED BY HLA-A*02 FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS
#6300METHODS OF TREATING SUPERFICIAL DIGITAL FLEXOR TENDON INJURIES, DEEP AND SUPERFICIAL MUSCLE/TENDON CONTRACTURE, NAVICULAR SYNDROME, AND SUSPENSORY LIGAMENT INFLAMMATION AND INJURIES IN QUADRUPED ANIMALS